EUVIMEDEUVIMED entdecken
Open Access

Microglia‐Mediated Synaptic Dysfunction Contributes to Chemotherapy‐Related Cognitive Impairment

Jingxiong Wang, Hua Zhang, Marc Augenreich, Luis Martinez-Lemus A, Zhenguo Liu, Xunlei Kang, Bo Lu, Hui-Ming Chang, Edward T H Yeh, Juan Cata, Srikant Rangaraju, Heike Wulff und 1 weitere

Journal of Neurochemistry · 2025-03 · 169 (3)

DOI: 10.1111/jnc.70024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurochemistry, online erschienen am 28.02.2025. Verfasst von Jingxiong Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Missouri-Columbia School of Medicine, Columbia, Missouri, USA. Hauptthemen laut MEDLINE: Microglia, Chemotherapy-Related Cognitive Impairment, Synapses, Cognitive Dysfunction. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, Department of Medicine, Center for Precision MedicineUniversity of Missouri, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemotherapy‐related cognitive impairment (CRCI) significantly impacts cancer survivors. Due to unclear mechanisms, effective treatments for cognitive deficits are lacking. Here, we examined if microglia‐mediated deficits in synaptic plasticity drive CRCI. Adult male mice were treated with the chemotherapeutic drugs 5‐fluorouracil and leucovorin (5‐Fu/LV, intraperitoneal injection, I.P.) on Days 1, 8, and 15 at a dosage of 50 mg/kg for 5‐Fu and 90 mg/kg for LV for 3 weeks. Cognitive function was assessed using a novel object recognition (NOR) test 4 weeks after completion of 5‐Fu/LV treatment. Compared with vehicle treatment, 5‐Fu/LV treatment reduced the preference for exploring novel objects in the NOR test. Treatment with 5‐Fu/LV increased the numbers of Iba1‐positive microglial and CD68‐positive/Iba1‐positive microglia with shortened process lengths and diminished endpoints but decreased the number of phagocytotic (≤ 1 FITC‐labeled beads) Iba1‐positive microglia. Furthermore, 5‐Fu/LV treatment reduced the long‐term potentiation (LTP) recorded in the hippocampal CA1 region in response to a theta burst stimulation of the CA3‐CA1 pathway and decreased the evoked N‐methyl‐D‐aspartic acid receptor (NMDAR)‐excitatory postsynaptic currents (NMDAR‐EPSCs) in CA1 neurons. Cotreatment with the microglial inhibitor minocycline (33 mg/kg, daily for 3 weeks) restored cognitive deficits and microglial ramification, decreased the number of CD68‐positive microglia, and reversed the reductions in LTP and the amplitude of NMDAR‐EPSCs in 5‐Fu/LV‐treated mice. Our data suggest that microglial dysfunction and related synaptic dysfunction contribute to 5‐Fu/LV‐induced cognitive impairment. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrogliaChemotherapy-Related Cognitive ImpairmentSynapsesCognitive DysfunctionAnimalsMaleMiceFluorouracilMice, Inbred C57BLLong-Term PotentiationNeuronal Plasticity

Stichwörter der Autor:innen

chemotherapycognitive deficitslong‐term potentiationmicrogliasynaptic transmission

Substanzen

Fluorouracil

Autor:innen und Institutionen

  • Department of Medicine, University of Missouri-Columbia School of Medicine, Columbia, Missouri, USA.
  • Department of Medical Pharmacology and Physiology, University of Missouri-Columbia School of Medicine, Columbia, Missouri, USA.
  • Department of Radiation Oncology, NextGen Precision Health, University of Missouri-Columbia School of Medicine, Columbia, Missouri, USA.
  • Departments of Pharmacology and Internal Medicine, The University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
  • Department of Internal Medicine, The University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
  • Department of Anesthesiology and Perioperative Medicine, The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.

ORCID-Profile: De-Pei Li

Förderung

  • NHLBI NIH HHS
  • Department of Medicine, Center for Precision MedicineUniversity of Missouri
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Wang, J., Zhang, H., Augenreich, M., Martinez-Lemus A, L., Liu, Z., Kang, X., Lu, B., Chang, H. M., Yeh, E. T. H., Cata, J., Rangaraju, S., Wulff, H., & Li, D. P. (2025). Microglia‐Mediated Synaptic Dysfunction Contributes to Chemotherapy‐Related Cognitive Impairment. Journal of Neurochemistry, 169(3). https://doi.org/10.1111/jnc.70024

Vancouver

Wang J, Zhang H, Augenreich M, Martinez-Lemus A L, Liu Z, Kang X, et al. Microglia‐Mediated Synaptic Dysfunction Contributes to Chemotherapy‐Related Cognitive Impairment. Journal of Neurochemistry. 2025;169(3). doi:10.1111/jnc.70024

BibTeX
@article{Wang2025,
  author = {Wang, Jingxiong and Zhang, Hua and Augenreich, Marc and Martinez-Lemus A, Luis and Liu, Zhenguo and Kang, Xunlei and Lu, Bo and Chang, Hui-Ming and Yeh, Edward T H and Cata, Juan and Rangaraju, Srikant and Wulff, Heike and Li, De-Pei},
  title = {Microglia‐Mediated Synaptic Dysfunction Contributes to Chemotherapy‐Related Cognitive Impairment},
  journal = {Journal of Neurochemistry},
  year = {2025},
  volume = {169},
  number = {3},
  doi = {10.1111/jnc.70024}
}
Kostenlos starten →